Skip to main content

Table 4 Overall and disease-free survival analysis of NKG2DLs MICA/B, ULBP1, ULBP2, ULBP3, RAET1E, and RAET1G

From: MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer

  Disease-Free Survival Time   Overall Survival Time  
  Mean 95% CI Log-rank P Mean 95% CI Log-rank P
MICA/B       
 Low (n = 112) 127 112-141 0.027 146 133-158 0.181
 High (n = 83) 164 150-178   169 155-183  
ULBP1       
 Low (n = 106) 125 110-140 0.009 139 125-152 0.007
 High (n = 77) 163 148-178   177 167-188  
ULBP2       
 Low (n = 93) 144 127-160 0.279 165 152-178 0.640
 High (n = 91) 148 134-163   155 141-169  
ULBP3       
 Low (n = 79) 136 121-151 0.364 147 134-160 0.707
 High (n = 101) 139 122-157   159 144-173  
RAET1E       
 Low (n = 123) 157 144-170 0.018 163 151-175 0.935
 High (n = 59) 116 96-137   149 135-164  
RAET1G       
 Low (n = 104) 159 146-172 0.029 166 154-179 0.234
 High (n = 80) 127 108-146   149 132-165  
  1. IHC staining scores of the NKG2DLs were dichotomized into low expression (≤ mean score of cancer specimens) and high expression (> mean score of cancer specimens).